Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
Business
AFP News

Pfizer Shares Tumble On Disappointing 2024 Profit Outlook

Pfizer CEO Albert Bourla said the purchse of Seagen would double the company's oncology product pipeline (Credit: AFP)

Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic.

The company, which reported more than $100 billion in revenue in 2022 due to the lift from Covid-19 vaccine and therapeutic sales, sees 2024 revenues of between $58.5 billion and $61.5 billion, according to its presentation.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.